中华消化内镜杂志
中華消化內鏡雜誌
중화소화내경잡지
CHINESE JOURNAL OF DIGESTIVE ENDOSCOPY
2015年
4期
229-233
,共5页
吴嘉钏%卢袆%方一%金正%别里克%徐贝黎%许春娣%夏璐%龚彪
吳嘉釧%盧袆%方一%金正%彆裏剋%徐貝黎%許春娣%夏璐%龔彪
오가천%로위%방일%금정%별리극%서패려%허춘제%하로%공표
内镜逆行胰胆管造影术%儿童和青少年%慢性胰腺炎
內鏡逆行胰膽管造影術%兒童和青少年%慢性胰腺炎
내경역행이담관조영술%인동화청소년%만성이선염
Endoscopic retrograde cholangiopancreatography%Pediatric population%Chronic pancreatitis
目的评价儿童及青少年(≤17岁)慢性胰腺炎患儿行经内镜逆行胰胆管造影术(ERCP)诊治的临床价值和安全性。方法回顾性收集2008年1月1日至2014年4月30日上海交通大学医学院附属瑞金医院消化内镜中心行 ERCP 诊治的87例儿童和青少年慢性胰腺炎患儿(2~17岁)的临床资料,按年龄段分成3组,2~6岁(幼儿组,n =27)、7~12岁(少年儿童组,n =35)、13~17岁(青少年组,n =25),统计分析各组内镜诊治情况及并发症发生情况。结果87例患儿共行170例次 ERCP 诊治,ERCP 操作总成功率为99.4%(169/170),均经 ERCP 明确诊断为慢性胰腺炎。ERCP操作成功率幼儿组为97.6%(40/41),少年儿童组为100.0%(72/72),青少年组亦为100.0%(57/57),3组间差异无统计学意义(P =0.207)。3组均无出血、穿孔等严重并发症,亦均无操作相关死亡病例,ERCP 术后并发症总发生率幼儿组、少年儿童组和青少年组分别为41.5%(17/41)、25.0%(18/72)和24.6%(14/57),幼儿组的术后并发症总发生率明显高于少年儿童组(P =0.039)和青少年组(P =0.045)。结论儿童和青少年慢性胰腺炎患儿行 ERCP 诊治是安全和有效的,但年龄小的慢性胰腺炎患儿发生 ERCP 术后并发症的风险可能更高。
目的評價兒童及青少年(≤17歲)慢性胰腺炎患兒行經內鏡逆行胰膽管造影術(ERCP)診治的臨床價值和安全性。方法迴顧性收集2008年1月1日至2014年4月30日上海交通大學醫學院附屬瑞金醫院消化內鏡中心行 ERCP 診治的87例兒童和青少年慢性胰腺炎患兒(2~17歲)的臨床資料,按年齡段分成3組,2~6歲(幼兒組,n =27)、7~12歲(少年兒童組,n =35)、13~17歲(青少年組,n =25),統計分析各組內鏡診治情況及併髮癥髮生情況。結果87例患兒共行170例次 ERCP 診治,ERCP 操作總成功率為99.4%(169/170),均經 ERCP 明確診斷為慢性胰腺炎。ERCP操作成功率幼兒組為97.6%(40/41),少年兒童組為100.0%(72/72),青少年組亦為100.0%(57/57),3組間差異無統計學意義(P =0.207)。3組均無齣血、穿孔等嚴重併髮癥,亦均無操作相關死亡病例,ERCP 術後併髮癥總髮生率幼兒組、少年兒童組和青少年組分彆為41.5%(17/41)、25.0%(18/72)和24.6%(14/57),幼兒組的術後併髮癥總髮生率明顯高于少年兒童組(P =0.039)和青少年組(P =0.045)。結論兒童和青少年慢性胰腺炎患兒行 ERCP 診治是安全和有效的,但年齡小的慢性胰腺炎患兒髮生 ERCP 術後併髮癥的風險可能更高。
목적평개인동급청소년(≤17세)만성이선염환인행경내경역행이담관조영술(ERCP)진치적림상개치화안전성。방법회고성수집2008년1월1일지2014년4월30일상해교통대학의학원부속서금의원소화내경중심행 ERCP 진치적87례인동화청소년만성이선염환인(2~17세)적림상자료,안년령단분성3조,2~6세(유인조,n =27)、7~12세(소년인동조,n =35)、13~17세(청소년조,n =25),통계분석각조내경진치정황급병발증발생정황。결과87례환인공행170례차 ERCP 진치,ERCP 조작총성공솔위99.4%(169/170),균경 ERCP 명학진단위만성이선염。ERCP조작성공솔유인조위97.6%(40/41),소년인동조위100.0%(72/72),청소년조역위100.0%(57/57),3조간차이무통계학의의(P =0.207)。3조균무출혈、천공등엄중병발증,역균무조작상관사망병례,ERCP 술후병발증총발생솔유인조、소년인동조화청소년조분별위41.5%(17/41)、25.0%(18/72)화24.6%(14/57),유인조적술후병발증총발생솔명현고우소년인동조(P =0.039)화청소년조(P =0.045)。결론인동화청소년만성이선염환인행 ERCP 진치시안전화유효적,단년령소적만성이선염환인발생 ERCP 술후병발증적풍험가능경고。
Objective To study the clinical value and the safety of endoscopic retrograde cholangio-pancreatography(ERCP)for chronic pancreatitis in the pediatric population.Methods Clinical data,endo-scopic reports,and radiography of chronic pancreatic patients aged from 2 to 17 years old who underwent ERCP between Jan.1,2008 and Apr.30,2014 at Endoscopy Center of Ruijin Hospital were reviewed.These patients were divided into 3 groups,patients aged from 2 to 6 years old as children group(n =27),patients aged from 7 to 12 years old as juvenile group(n =35)and patients aged from 13 to 17 as adolescent group(n =25). Their clinical data and complications were analyzed by groups.Results A total of 170 ERCP procedures were performed in 87 patients,with the success rate of 99.4%(169 /170).All patients were diagnosed as having chronic pancreatitis by ERCP.Success rates of children group,juvenile group and adolescent group were 97.6%(40 /41),100.0%(72 /72)and 100.0%(57 /57)respectively.There was no statistically significance among the three groups(P =0.207).No serious complications like bleeding or perforation occurred.No proce-dure-related mortality occurred in this study either.The rate of post-ERCP adverse events in children group, juvenile group and adolescent group were 41.5%(17 /41),25.0%(18 /72)and 24.6%(14/57),respective-ly.Children group had more adverse events than the juvenile group(P =0.039)and adolescent group(P =0.045).Conclusion Pediatric ERCP is highly effective in the pediatric population with chronic pancreatitis. The incidence of post ERCP adverse events is higher among the youngest children.